| PPI‐Detect: a support vector machine model for sequence‐based prediction of protein–protein interactions S Romero‐Molina, YB Ruiz‐Blanco, M Harms, J Münch, ... Journal of computational chemistry 40 (11), 1233-1242, 2019 | 72 | 2019 |
| Macromolecular antiviral agents against Zika, Ebola, SARS, and other pathogenic viruses F Schandock, CF Riber, A Röcker, JA Müller, M Harms, P Gajda, ... Advanced Healthcare Materials 6 (23), 1700748, 2017 | 71 | 2017 |
| Inactivation and environmental stability of Zika virus JA Müller, M Harms, A Schubert, S Jansen, D Michel, T Mertens, ... Emerging infectious diseases 22 (9), 1685, 2016 | 71 | 2016 |
| Semen inhibits Zika virus infection of cells and tissues from the anogenital region JA Müller, M Harms, F Krüger, R Groß, S Joas, M Hayn, AN Dietz, ... Nature communications 9 (1), 2207, 2018 | 56 | 2018 |
| PPI-affinity: A web tool for the prediction and optimization of protein–peptide and protein–protein binding affinity S Romero-Molina, YB Ruiz-Blanco, J Mieres-Perez, M Harms, J Münch, ... Journal of proteome research 21 (8), 1829-1841, 2022 | 54 | 2022 |
| Development of a high-throughput colorimetric Zika virus infection assay JA Müller, M Harms, A Schubert, B Mayer, S Jansen, JP Herbeuval, ... Medical Microbiology and Immunology 206, 175-185, 2017 | 49 | 2017 |
| Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement—a new target for lupus treatment N Smith, MP Rodero, N Bekaddour, V Bondet, YB Ruiz-Blanco, M Harms, ... Science Advances 5 (7), eaav9019, 2019 | 47 | 2019 |
| The molecular tweezer CLR01 inhibits Ebola and Zika virus infection AE Röcker, JA Müller, E Dietzel, M Harms, F Krüger, C Heid, A Sowislok, ... Antiviral research 152, 26-35, 2018 | 45 | 2018 |
| An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation M Harms, MMW Habib, S Nemska, A Nicolo, A Gilg, N Preising, P Sokkar, ... Acta Pharmaceutica Sinica B 11 (9), 2694-2708, 2021 | 41 | 2021 |
| Supramolecular mechanism of viral envelope disruption by molecular tweezers T Weil, R Groß, A Röcker, K Bravo-Rodriguez, C Heid, A Sowislok, ... Journal of the American Chemical Society 142 (40), 17024-17038, 2020 | 37 | 2020 |
| Microtiter plate-based antibody-competition assay to determine binding affinities and plasma/blood stability of CXCR4 ligands M Harms, A Gilg, L Ständker, AJ Beer, B Mayer, V Rasche, CW Gruber, ... Scientific reports 10 (1), 16036, 2020 | 27 | 2020 |
| Storage-dependent generation of potent anti-ZIKV activity in human breast milk C Conzelmann, M Zou, R Groß, M Harms, A Röcker, CU Riedel, J Münch, ... Viruses 11 (7), 591, 2019 | 25 | 2019 |
| Computational modeling and experimental validation of the EPI-X4/CXCR4 complex allows rational design of small peptide antagonists P Sokkar, M Harms, C Stürzel, A Gilg, G Kizilsavas, M Raasholm, ... Communications Biology 4 (1), 1113, 2021 | 24 | 2021 |
| Targeting of CXCR4 by the naturally occurring CXCR4 antagonist EPI-X4 in Waldenström’s macroglobulinemia LM Kaiser, M Harms, D Sauter, VPS Rawat, M Glitscher, E Hildt, D Tews, ... Cancers 13 (4), 826, 2021 | 24 | 2021 |
| Natural inhibitor of human cytomegalovirus in human seminal plasma S Lippold, B Braun, F Krüger, M Harms, JA Müller, R Groß, J Münch, ... Journal of Virology 93 (6), 10.1128/jvi. 01855-18, 2019 | 23 | 2019 |
| Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling M Hayn, A Blötz, A Rodríguez, S Vidal, N Preising, L Ständker, S Wiese, ... Proceedings of the National Academy of Sciences 118 (3), e2023776118, 2021 | 18 | 2021 |
| Advanced EPI-X4 derivatives covalently bind human serum albumin resulting in prolonged plasma stability A Rodríguez-Alfonso, A Heck, YB Ruiz-Blanco, A Gilg, L Ständker, ... International Journal of Molecular Sciences 23 (23), 15029, 2022 | 11 | 2022 |
| Dimerization of the peptide CXCR4-antagonist on macromolecular and supramolecular protraction arms affords increased potency and enhanced plasma stability M Harms, RF Hansson, S Carmali, Y Almeida-Hernández, ... Bioconjugate Chemistry 33 (4), 594-607, 2022 | 8 | 2022 |
| Spermine and spermidine bind CXCR4 and inhibit CXCR4-but not CCR5-tropic HIV-1 infection M Harms, N Smith, M Han, R Groß, P Von Maltitz, C Stürzel, ... Science Advances 9 (27), eadf8251, 2023 | 5 | 2023 |
| Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability M Harms, R Fabech Hansson, A Gilg, Y Almeida-Hernández, J Löffler, ... Journal of Medicinal Chemistry 66 (22), 15189-15204, 2023 | 4 | 2023 |
